BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Garcia-tsao G. The transjugular intrahepatic portosystemic shunt for the management of cirrhotic refractory ascites. Nat Rev Gastroenterol Hepatol 2006;3:380-9. [DOI: 10.1038/ncpgasthep0523] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Caly WR, Abreu RM, Bitelman B, Carrilho FJ, Ono SK. Clinical Features of Refractory Ascites in Outpatients. Clinics (Sao Paulo). 2017;72:405-410. [PMID: 28792999 DOI: 10.6061/clinics/2017(07)03] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
2 De Gottardi A, Thévenot T, Spahr L, Morard I, Bresson-Hadni S, Torres F, Giostra E, Hadengue A. Risk of complications after abdominal paracentesis in cirrhotic patients: a prospective study. Clin Gastroenterol Hepatol 2009;7:906-9. [PMID: 19447197 DOI: 10.1016/j.cgh.2009.05.004] [Cited by in Crossref: 118] [Cited by in F6Publishing: 77] [Article Influence: 9.8] [Reference Citation Analysis]
3 Zamberg I, Maillard J, Assouline B, Tomala S, Keli-Barcelos G, Aldenkortt F, Mavrakanas T, Andres A, Schiffer E. Perioperative Evolution of Sodium Levels in Cirrhotic Patients Undergoing Liver Transplantation: An Observational Cohort and Literature Review. Hepat Med 2021;13:71-82. [PMID: 34393524 DOI: 10.2147/HMER.S320127] [Reference Citation Analysis]
4 刘锋, 张春清. 经皮经肝肝内门体分流术后肝性脑病发病机制及其预防. 世界华人消化杂志 2009; 17(8): 798-804 [DOI: 10.11569/wcjd.v17.i8.798] [Reference Citation Analysis]
5 Colombato L. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension. J Clin Gastroenterol. 2007;41 Suppl 3:S344-S351. [PMID: 17975487 DOI: 10.1097/mcg.0b013e318157e500] [Cited by in Crossref: 90] [Cited by in F6Publishing: 32] [Article Influence: 6.9] [Reference Citation Analysis]
6 Chen RP, Zhu Ge XJ, Huang ZM, Ye XH, Hu CY, Lu GR, Lu de Y, Phemba IL. Prophylactic use of transjugular intrahepatic portosystemic shunt aids in the treatment of refractory ascites: metaregression and trial sequential meta-analysis. J Clin Gastroenterol. 2014;48:290-299. [PMID: 24030734 DOI: 10.1097/mcg.0b013e3182a115e9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
7 Reilly CR, Babushok DV, Martin K, Spivak JL, Streiff M, Bahirwani R, Mondschein J, Stein B, Moliterno A, Hexner EO. Multicenter analysis of the use of transjugular intrahepatic portosystemic shunt for management of MPN-associated portal hypertension. Am J Hematol 2017;92:909-14. [PMID: 28543980 DOI: 10.1002/ajh.24798] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
8 Bai M, Qi X, Yang Z, Yin Z, Nie Y, Yuan S, Wu K, Han G, Fan D. Predictors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: a systematic review. J Gastroenterol Hepatol. 2011;26:943-951. [PMID: 21251067 DOI: 10.1111/j.1440-1746.2011.06663.x] [Cited by in Crossref: 97] [Cited by in F6Publishing: 78] [Article Influence: 9.7] [Reference Citation Analysis]
9 Bannas P, Roldán-Alzate A, Johnson KM, Woods MA, Ozkan O, Motosugi U, Wieben O, Reeder SB, Kramer H. Longitudinal Monitoring of Hepatic Blood Flow before and after TIPS by Using 4D-Flow MR Imaging. Radiology 2016;281:574-82. [PMID: 27171019 DOI: 10.1148/radiol.2016152247] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
10 Hayek G, Ronot M, Plessier A, Sibert A, Abdel-Rehim M, Zappa M, Rautou PE, Valla D, Vilgrain V. Long-term Outcome and Analysis of Dysfunction of Transjugular Intrahepatic Portosystemic Shunt Placement in Chronic Primary Budd-Chiari Syndrome. Radiology. 2017;283:280-292. [PMID: 27797679 DOI: 10.1148/radiol.2016152641] [Cited by in Crossref: 33] [Cited by in F6Publishing: 22] [Article Influence: 6.6] [Reference Citation Analysis]
11 Garcia-Tsao G, Lim JK; Members of Veterans Affairs Hepatitis C Resource Center Program. Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program. Am J Gastroenterol. 2009;104:1802-1829. [PMID: 19455106 DOI: 10.1038/ajg.2009.191] [Cited by in Crossref: 168] [Cited by in F6Publishing: 145] [Article Influence: 14.0] [Reference Citation Analysis]
12 Copelan A, Kapoor B, Sands M. Transjugular intrahepatic portosystemic shunt: indications, contraindications, and patient work-up. Semin Intervent Radiol. 2014;31:235-242. [PMID: 25177083 DOI: 10.1055/s-0034-1382790] [Cited by in Crossref: 48] [Cited by in F6Publishing: 24] [Article Influence: 6.9] [Reference Citation Analysis]
13 Garcia-tsao G. Ascites. Zakim and Boyer's Hepatology. Elsevier; 2012. pp. 283-95. [DOI: 10.1016/b978-1-4377-0881-3.00018-8] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]